Silicon Valley Capital Partners »

Terns Pharmaceuticals shares owned by Silicon Valley Capital Partners

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Silicon Valley Capital Partners from 13F filings

Historical chart of Silicon Valley Capital Partners investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by Silicon Valley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by Silicon Valley Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5k 67 52.72

More positions owned by Silicon Valley Capital Partners

State Street Spdr S&p 500 Etf Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Information Technology Etf Etf (VGT)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Apple Stock (AAPL)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Meta Platforms Inc Cl A Stock (META)
Ishares 3-7 Year Treasury Bond Etf Etf (IEI)
Amazon Stock (AMZN)
Broadcom Stock (AVGO)
Ishares S&p 500 Growth Etf Etf (IVW)
Advanced Micro Devices Stock (AMD)
Oracle Corp Stock (ORCL)

View all positions for Silicon Valley Capital Partners

Top funds holding Terns Pharmaceuticals

BlackRock
Morgan Stanley
Adage Capital Partners GP
Vanguard Group
Vanguard Capital Management
venBio Select Advisor
Holocene Advisors
Balyasny Asset Management
Citadel Advisors
Millennium Management
HBK Investments
Lord, Abbett & Co
Ikarian Capital
Franklin Resources
Geode Capital Management

View all funds holding Terns Pharmaceuticals